News
Company news and developments, with original sources and dates.
Updated from source
Funding RSS ↗Flexcompute Secures Strategic Investment for Physics World Model
According to Unite.AI, on October 12, 2026, Boston-based Flexcompute announced a strategic investment from Samsung Ventures and Applied Ventures, the VC arm of Applied Materials, among others; the amount was undisclosed. The funding will grow its research team and GPU compute to advance the Physics World Model across fluids, electromagnetics and structures.
Multiply Labs raises USD 75 million in Series B funding to automate pharmaceutical manufacturing with robots
On 2026/10/8, AIPressRoom reported that Multiply Labs raised USD 75 million in Series B funding, led by Patrick Soon-Shiong and NantWorks. It uses robotic systems to automate biologic drug production, improving pharmaceutical manufacturing efficiency and quality consistency.
ServiceNow to Acquire Armis for $7.75B at $340M+ ARR
On October 7, 2026, per Briefly, ServiceNow agreed to acquire US cybersecurity firm Armis for $7.75 billion; Armis has $340 million+ ARR.
SK hynix’s Solidigm considers IPO, potentially targeting USD 150 billion valuation
On 2026/10/5, Phoenix Finance reported that Solidigm, a US subsidiary of South Korean semiconductor manufacturer SK hynix, was considering an IPO as early as next year, potentially targeting a valuation up to USD 150 billion. If completed, it could set a semiconductor IPO record, exceeding Arm’s approximately USD 54 billion and Cerebras’ approximately USD 56 billion listing valuations.
Armadin raises USD 255.5 million Series B at valuation exceeding USD 2.5 billion
According to Unite.AI, on 2026/10/1, AI-native cybersecurity company Armadin raised USD 255.5 million in Series B funding at a valuation exceeding USD 2.5 billion, co-led by Andreessen Horowitz and Accel, with Bain Capital Ventures, Redpoint and others participating. It validates attack paths for enterprises through autonomous agent attack swarms, serving Fortune 500 companies and government customers. Total funding reached USD 445 million. Travis Lanham, Evan Peña and David Slater co-founded the company.
Varda Space Industries raises $251M Series D
On 2026/9/30, according to genztech, US space pharmaceutical company Varda Space Industries raised USD251 million in Series D financing. Investors included Lux Capital and Natural Capital. The company manufactures drug crystals in orbit.
Basecamp Research raises USD 140 million in Series C+ financing
On 2026-09-24, according to Xiniu Data, Basecamp Research completed Series C+ financing, raising USD 140 million. Investors were lead investor S32, True Ventures, Sovereign AI Fund, Singular and others. The company is a developer of British AI biological pharmaceutical.
Yunhe Pharma Secures Equity Investment
On September 22, 2026, Suzhou-based Yunhe Zhiyao, a biopharmaceutical developer, completed an equity investment from Guanghua Wutong, Xiaochi Capital, Wutong Juyun and Ruishang Pharma.
Mithrl raises USD 20 million in Series A financing
On 2026-09-18, according to Xiniu Data, Mithrl completed Series A financing, raising USD 20 million. Investors were lead investor Obvious Ventures. The company is a provider of intelligent AI infrastructure services for biopharmaceuticals.
Horizon Robotics subsidiary D-Robotics raises USD 400 million Series C
On 2026/9/17, D-Robotics, a robotics subsidiary of Horizon Robotics, announced USD 400 million in Series C funding led by Mirae Asset. Follow-on investors included Meituan’s strategic investment arm, government-backed platforms including Hefei Guotou and Nanshan Zhanxintou, and leading institutions including Cathay Capital, GF Xinde and GL Ventures. Since its Series A in 2025, D-Robotics had disclosed USD 770 million in cumulative funding.
Chemify receives GBP 22 million in government grants for Chemifarm expansion
On 2026/9/16, Scottish Enterprise announced GBP 22 million in government support for Chemify, including GBP 16 million from Scottish Enterprise and GBP 6 million from the UK government. Total project investment was GBP 89.9 million, including GBP 67.9 million from the company itself. Government grants must not be described as equity financing.
Graph AI raises USD 13.3 million in Series A financing
On 2026-09-10, according to Xiniu Data, Graph AI completed Series A financing, raising USD 13.3 million. Investors were lead investor Insight Partners, participating investor Bessemer Venture Partners. The company is a provider of AI pharmacovigilance and patient safety platforms.
Weifenzhifei raises hundreds of millions of RMB in Series A financing
On 2026-09-03, according to Xiniu Data, Weifenzhifei completed Series A financing, raising hundreds of millions of RMB. Investors were lead investor Puhua Capital, participating investor Honghui Fund, participating investor Changsanjiaoshuzhiwenhua Industry Private Investment Fund (Shanghai) Partnership (Limited Partnership), participating investor Wuyuan Capital, participating investor Shen Venture Capital, participating investor Hongtai Fund, participating investor Huaying Capital, participating investor Huakong Fund, participating investor Changshi Capital, participating investor BV Baidufengtou, other participating investors. The company is a developer of flying embodied brains and general-purpose swarm intelligence systems.
Woshi Technology completes equity financing
On 2026-08-19, according to Xiniu Data, Woshi Technology completed equity financing for an undisclosed amount. Investors were Hunan Yuwozhisuan Venture Capital Partnership (Limited Partnership), Foshanshengjieguquan Investment Partnership (Limited Partnership), Suzhou Suchuangzhihuirencai Venture Capital Partnership (Limited Partnership), Hangzhou Yuanqiaozhilongguquan Investment Partnership (Limited Partnership). The company is an AI decision platform for the pharmaceutical industry.
iRegene completes equity financing
On 2026-08-18, according to Xiniu Data, iRegene completed equity financing for an undisclosed amount. Investors were Sichuan Shengchengguozhuanhua Investment Yindao Fund Partnership (Limited Partnership), Chengdu Hongsheng Phase One Venture Capital Partnership (Limited Partnership), Wuxi City Biotechnology Pharmaceutical Industry Fund (Limited Partnership), Shenzhen City Pengyuanjishi Private Equity Investment Fund Partnership (Limited Partnership), Chengdu Weilai Industry Venture Capital Development Fund Partnership (Limited Partnership), Shanghai Dingtaixing Technology Development Co., Ltd.. The company is a developer of chemically induced cell therapy drugs.
Aurelius Systems Raises $40M Series A for Counter-Drone Systems
On August 5, 2026, per Aurelius Systems, AI-assisted directed energy counter-drone company raised $40M in a Series A co-led by Draper Associates and KAS Venture Partners with General Catalyst, Hanwha-affiliated funds and other defense tech investors. The company was founded in 2024 by Michael LaFramboise, John Marmaduke and others.
Olix completes equity financing
On 2026-08-03, according to Xiniu Data, Olix completed equity financing, raising USD 312 million. Investors were lead investor Fundomo, participating investor Arm, participating investor Hudson River Trading, participating investor Lide · Hasitingsi. The company is a developer of British AI chips.
Arm first-quarter fiscal revenue reaches USD 1.289 billion, up 22.41% year over year
On 2026/7/30, IT Home reported that UK chip design company Arm generated USD 1.289 billion in first-quarter fiscal revenue, up 22.41% year over year, driven by cloud data center demand and a higher share of the Armv9 architecture.
India Building Materials Platform Fixxly Raises $5.5M Seed Led by Accel
On July 29, 2026, per Fixxly, Indian building materials instant retail platform Fixxly raised $5.5M in seed funding led by Accel with Fireside Ventures and Lightspeed India Partners. The company provides on-demand procurement and delivery for the construction industry, co-founded in 2026 by Shezan Bhojani and Sachith Varma.
Harmony Raises $34M Seed Led by Lightspeed for Internal Services AI Agents
On July 28, 2026, per Harmony, internal services AI agent company Harmony raised $34M in seed funding led by Lightspeed Venture Partners with Hitachi Ventures, Fin Capital, Mercer Ventures and Operator Partners. The company was co-founded by Nitzan Shapira and Ran Ribenzaft, who previously built cloud observability company Epsagon and sold it to Cisco.
PharmacyX reaches GBP 2 million in ARR, serving over 300 pharmacies
On 2026/7/15, LinkedIn reported that UK company PharmacyX reached GBP 2 million in ARR and served more than 300 pharmacies. It provides a patient medication record platform for independent UK pharmacies and grows primarily through word of mouth.
Walden Robotics Raises $300M Seed at $1.1B Valuation for Dual-Arm Robots
On July 15, 2026, per Walden Robotics, dual-arm robot company for manufacturing and logistics raised $300M in seed funding at a $1.1B valuation, led by Toyota-affiliated entities and Deviation Capital with NVIDIA, Boeing, Samsung Ventures and Menlo. The company was founded by MIT professor Russ Tedrake and others, spinning out of Toyota Research Institute in 2026.
Hippo Harvest raises USD 30 million in Series C financing
On 2026-07-13, according to Xiniu Data, Hippo Harvest completed Series C financing, raising USD 30 million. Investors were lead investor Cox Farms, participating investor Congruent Ventures, participating investor Hawthorne Food Ventures, other participating investors. The company is a developer of U.S. agricultural technology.
Yaowumuchang raises USD 55 million in Series D financing
On 2026-07-13, according to Xiniu Data, Yaowumuchang completed Series D financing, raising USD 55 million. Investors were lead investor Pudong Venture Capital Group, participating investor Zhikai Capital, participating investor Shenzhen City Luohudonghairuizhi Pharmaceutical Industrial Investment Partnership (Limited Partnership), participating investor Keyuanzhiyao, participating investor Baiaoweida, participating investor YD Capital, participating investor Jiashanguotou, participating investor Detong Capital, participating investor Weidu Capital, participating investor Biometas. The company is a novel drug developer.